Carregant...
Oxidative Stress and Proteasome Inhibitors in Multiple Myeloma
Multiple myeloma is a form of plasma cell neoplasm that accounts for approximately 10% of all hematological malignancies. Recently, several novel drugs have been discovered that almost doubled the overall survival of multiple myeloma patients. One of these drugs, the first-in-class proteasome inhibi...
Guardat en:
| Publicat a: | Pharmacol Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5044866/ https://ncbi.nlm.nih.gov/pubmed/26827824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2016.01.029 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|